An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Chen, Christine I. [1 ]
Paul, Harminder [1 ]
Snitzler, Susi [1 ]
Le, Lisa W. [2 ]
Wei, Ellen Nong [1 ]
Lau, Anthea [2 ]
Johnston, James B. [3 ]
Gibson, Spencer B. [4 ]
Queau, Michelle L. [4 ]
Trudel, Suzanne [1 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[3] Canc Care Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
[4] Canc Care Manitoba, Res Inst Oncol & Hematol, Winnipeg, MB, Canada
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Del Rizzo, Luisa
    Le, Lisa W.
    Wei, Ellen Nong
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Brown, Michelle
    Trudel, Suzanne
    BLOOD, 2012, 120 (21)
  • [2] A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Kakar, Sumeet
    Le, Lisa W.
    Wei, Ellen N.
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle
    Spaner, David
    Croucher, Danielle
    Sherry, Barbara
    Trudel, Suzanne
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 980 - 989
  • [3] A phase II study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Mariela, Pantoja
    Brandwein, Joseph
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Tong, Jieffei
    Moran, Mike
    BLOOD, 2007, 110 (11) : 608A - 608A
  • [4] A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Xu, Wei
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Leung-Hagensteijn, Chungyee
    BLOOD, 2008, 112 (11) : 23 - 23
  • [5] Long-Term Follow-up of a Phase 2 Study of Single Agent Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Wang, Trina
    Le, Lisa W.
    Kukreti, Vishal
    Wei, Ellen Nong
    Lau, Anthea
    Bergsagel, P. Leif
    Dave, Nimisha
    Trudel, Suzanne
    BLOOD, 2012, 120 (21)
  • [6] a Phase 2 Study of Alemtuzumab-Ofatumumab (A plus O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Ma, Shuo
    Rosen, Steven T.
    Frankfurt, Olga
    Winter, Jane N.
    Kreutzer, Jennifer
    Husa, Sonja
    Otsterborg, Anders
    Lundin, Jeanette
    BLOOD, 2014, 124 (21)
  • [7] Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia
    Soumerai, Jacob D.
    Davids, Matthew S.
    Werner, Lillian
    Fisher, David C.
    Armand, Philippe
    Amrein, Philip C.
    Neuberg, Donna
    Hochberg, Ephraim P.
    Brown, Jennifer R.
    Abramson, Jeremy S.
    LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 2931 - 2938
  • [8] A Phase 2 Study of Alemtuzumab-Ofatumumab (A plus O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) - an Update
    Lundin, Jeanette
    Rosen, Steven T.
    Osterborg, Anders
    Frankfurt, Olga
    Winter, Jane N.
    Rademaker, Alfred
    Kreutzer, Jennifer
    Bacon, Elizabeth
    Sonnert-Husa, Sonja
    Ma, Shuo
    BLOOD, 2015, 126 (23)
  • [9] Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia
    Byrd, John C.
    Flynn, Joseph M.
    Kipps, Thomas J.
    Boxer, Michael
    Kolibaba, Kathryn S.
    Carlile, David J.
    Fingerle-Rowson, Guenter
    Tyson, Nicola
    Hirata, Jamie
    Sharman, Jeff P.
    BLOOD, 2016, 127 (01) : 79 - 86
  • [10] Phase 1 Trial of Flavopiridol and Lenalidomide In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL)
    Blum, Kristie A.
    Jones, Jeffrey A.
    Andritsos, Leslie
    Flynn, Joseph M.
    Deam, Deidre
    Heerema, Nyla A.
    Phelps, Mitchell
    Johnson, Amy J.
    Grever, Michael R.
    Byrd, John C.
    BLOOD, 2010, 116 (21) : 1027 - 1027
12345